Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Life Sciences|June 23, 2004
The antidepressant mechanism of Hypericum perforatumTiziana Mennini, Marco Gobbi
Central Nervous System Agents in Medicinal Chemistry|June 4, 2010
Are descending control pathways of the lower urinary tract and pain overlapping systems?Tiziana Mennini, Rodolfo Testa
Methods in Molecular Medicine|April 6, 2004
Immunohistochemical localization of TNFalpha and its receptors in the rodent central nervous systemPaolo Bigini, Tiziana Mennini
Journal of Neuroscience Methods|October 20, 2006
Dimethyl sulfoxide: an antagonist in scintillation proximity assay [(35)S]-GTPgammaS binding to rat 5-HT(6) receptor cloned in HEK-293 cells?Ilario Mereghetti, Alfredo Cagnotto, Tiziana Mennini
Journal of Neuroscience Methods|February 20, 2008
Morphological features and responses to AMPA receptor-mediated excitotoxicity of mouse motor neurons: comparison in purified, mixed anterior horn or motor neuron/glia coculturesMassimiliano De Paola, Valentina Diana, Paolo Bigini, et al.
European Journal of Pharmacology|November 27, 2007
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1Elena Fumagalli, Marcella Funicello, Thomas Rauen, et al.
Neurochemistry International|July 7, 2009
Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of the wobbler mouse: a model of motor neuron diseaseGiambattista Bonanno, Elena Fumagalli, Marco Milanese, et al.
Experimental Neurology|January 3, 2006
Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative diseaseElena Fumagalli, Paolo Bigini, Sara Barbera, et al.
Planta Medica|August 12, 2004
In vitro effects of the dicyclohexylammonium salt of hyperforin on interleukin-6 release in different experimental modelsMarco Gobbi, Manuela Moia, Marcella Funicello, et al.
European Journal of Pharmacology|November 13, 2003
Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerationsTiziana Mennini, Elena Fumagalli, Marco Gobbi, et al.
Pageof 7